RPG Life Sciences Q1 net profit jumps 17% on strong domestic formulations, API growth

Shares of RPG Life Sciences Ltd ended at ₹2,895.95, down by ₹22.60, or 0.77%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *